sr141716 has been researched along with Hypothermia, Accidental in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 10 (38.46) | 29.6817 |
2010's | 13 (50.00) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Adolfs, TJ; Borst, AJ; Coolen, HK; de Looff, W; Keizer, HG; Kruse, CG; Lange, JH; McCreary, AC; van Stuivenberg, HH; Veerman, W; Verveer, PC; Wals, HC | 1 |
Armstrong, HE; Chang, LL; Chen, J; Colandrea, VJ; Fong, TM; Galka, A; Goulet, MT; Guthikonda, R; Ha, S; Hagmann, WK; Jewell, JP; Lanza, TJ; Lao, J; Lin, LS; Quaker, G; Rosko, K; Shah, SK; Shearman, LP; Shen, CP; Strack, A; Stribling, DS; Tong, X; Truong, Q; Van der Ploeg, L; Wang, J; Xu, S | 1 |
Cano, C; Girón, R; Goya, P; Martín, MI; Paez, JA; Sánchez, E | 1 |
Alig, L; Alsenz, J; Andjelkovic, M; Bénardeau, A; Bendels, S; Bleicher, K; Bourson, A; David-Pierson, P; Guba, W; Hildbrand, S; Kube, D; Lübbers, T; Mayweg, AV; Narquizian, R; Neidhart, W; Nettekoven, M; Plancher, JM; Rocha, C; Rogers-Evans, M; Röver, S; Schneider, G; Taylor, S; Waldmeier, P | 1 |
Bülow, A; Burstein, ES; Craig, D; Currier, EA; Del Tredici, AL; Ek, F; Fejzic, A; Gardell, LR; Jensen, J; Ma, JN; McFarland, K; Olsson, R; Ott, TR; Ottesen, LK; Pettersson, H; Piu, F; Tabatabaei, A | 1 |
Baker, J; Cowley, P; Edwards, D; Ho, KK; Jokiel, P; Letourneau, JJ; McAleer, L; Ohlmeyer, MH; Olson, J; Riviello, CM; Swanson, RN; Ward, N; Webb, ML; Yang, J | 1 |
Fantegrossi, WE; Hiranita, T; Wilson, CD | 1 |
Grel, A; Metna-Laurent, M; Mondésir, M; Piazza, PV; Vallée, M | 1 |
Blunder, M; Flores-Soto, ME; Gachet, MS; Gertsch, J; Nicolussi, S; Rau, M; Viveros-Paredes, JM | 1 |
Abdelrahman, M; Gamage, TF; Greig, IR; Ignatowska-Jankowska, BM; Lichtman, AH; Pertwee, RG; Poklis, J; Ross, RA; Thakur, GA; Tichkule, R; Trembleau, L; Wiley, JL | 1 |
McMahon, LR; Rodriguez, JS | 1 |
Creehan, KM; Taffe, MA; Vandewater, SA | 1 |
Aaltonen, N; Gynther, M; Jakupovic, H; Kedzierska, E; Laitinen, JT; Lehtonen, M; Navia-Paldanius, D; Nevalainen, T; Orzelska-Górka, J; Parkkari, T; Savinainen, JR | 1 |
Ahn, GJ; Chae, HW; Chae, YN; Choi, SH; Kim, HD; Kim, MK; Kim, SH; Moon, HS; Park, KJ; Shin, CY; Shin, YG; Son, MH; Yang, EK; Yoon, SH | 1 |
Carroll, FI; Gilliam, AF; Gilmour, BP; King, LS; Navarro, HA; Seltzman, HH; Thomas, BF; Twine, CE; Vann, RE; Walentiny, DM; Warner, JA; Wiley, JL | 1 |
DeLong, GT; Lichtman, AH; Poklis, A; Wolf, CE | 1 |
McMahon, LR; Schulze, DR; Singh, H | 1 |
Almeida, MC; Balaskó, M; Dogan, MD; Eales, J; Gavva, NR; Molchanova, AY; Oliveira, DL; Patel, S; Pétervári, E; Romanovsky, AA; Steiner, AA; Székely, M; Wanner, SP | 1 |
Cavallo, JS; Chain, DC; Dressler, HM; Economides, KD; Fan, C; Favara, SG; Galzin, AM; Guillot, E; Naimi, S; Palejwala, VA; Pang, Z; Polites, HG; Pruniaux, MP; Schaffer, E; Tocci, MJ; Weinstock, D; Wu, NN; Yamdagni, P; Zhang, X; Zhao, W | 1 |
Cowan, A; Ding, Z; Rawls, SM | 2 |
Ding, Z; Rawls, SM; Rodriguez, T; Schroeder, JA; Zaveri, N | 1 |
Koek, W; McMahon, LR | 1 |
Brown, RE; Dastur, FN; McGregor, IS; McLellan, RA | 1 |
Hanoune, J; Hutcheson, DM; Maldonado, R; Roques, BP; Smadja, C; Tzavara, ET; Valjent, E | 1 |
Filliol, D; Ghozland, S; Kieffer, BL; Maldonado, R; Matthes, HW; Simonin, F | 1 |
26 other study(ies) available for sr141716 and Hypothermia, Accidental
Article | Year |
---|---|
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists.
Topics: Administration, Oral; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Hypotension; Hypothermia; Imidazoles; Mice; Models, Molecular; Molecular Conformation; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 2005 |
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists.
Topics: Animals; Anti-Obesity Agents; Brain Chemistry; Cannabinoid Receptor Modulators; Humans; Hypothermia; Inhibitory Concentration 50; Pharmacokinetics; Rats; Receptor, Cannabinoid, CB1; Structure-Activity Relationship; Sulfonamides | 2007 |
Discovery of 1,1-dioxo-1,2,6-thiadiazine-5-carboxamide derivatives as cannabinoid-like molecules with agonist and antagonist activity.
Topics: Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Hypothermia; Injections, Intraperitoneal; Locomotion; Male; Mice; Mice, Inbred ICR; Molecular Structure; Morpholines; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Stereoisomerism; Thiadiazines; Vas Deferens | 2007 |
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.
Topics: Animals; Anti-Obesity Agents; Benzodioxoles; Body Weight; Crystallography, X-Ray; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Humans; Hypothermia; Ligands; Male; Mice; Microsomes; Models, Molecular; Molecular Structure; Obesity; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Structure-Activity Relationship | 2008 |
Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.
Topics: Animals; Anti-Obesity Agents; Appetite Depressants; Cell Line; Combinatorial Chemistry Techniques; Dibenzothiazepines; Drug Inverse Agonism; Eating; Humans; Hypothermia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Models, Molecular; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Solubility; Structure-Activity Relationship; Thiazepines | 2009 |
Identification and hit-to-lead optimization of a novel class of CB1 antagonists.
Topics: Animals; Benzimidazoles; Humans; Hypothermia; Indoles; Male; Mice; Microsomes, Liver; Obesity; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Solubility; Structure-Activity Relationship | 2010 |
Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
Topics: Amides; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Humans; Hypothermia; Indazoles; Male; Mice; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders; Tremor; Valine | 2022 |
Cannabinoid-Induced Tetrad in Mice.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Catalepsy; Disease Models, Animal; Dronabinol; Exploratory Behavior; Hypothermia; Male; Mice; Mice, Inbred C57BL; Movement Disorders; Piperidines; Pyrazoles; Rimonabant | 2017 |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Topics: Alkenes; Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Biological Transport; Brain; Cannabinoid Receptor Antagonists; Catalepsy; Dose-Response Relationship, Drug; Endocannabinoids; Fatty Acid-Binding Proteins; Glycerides; Heterocyclic Compounds, 2-Ring; Humans; Hypothermia; Locomotion; Male; Mice; Mice, Inbred BALB C; Monoacylglycerol Lipases; Neoplasm Proteins; Piper; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Serine Endopeptidases; Structure-Activity Relationship; U937 Cells | 2014 |
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
Topics: Allosteric Regulation; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catalepsy; Cyclohexanols; Dronabinol; Drug Evaluation; Eating; Endocannabinoids; Female; Hypothermia; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Nociception; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2014 |
JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
Topics: Animals; Benzoxazines; Body Temperature; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Conditioning, Operant; Cyclohexanols; Discrimination Learning; Dronabinol; Hypothermia; Indoles; Macaca mulatta; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2014 |
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Topics: Animals; Body Temperature; Cannabidiol; Cannabinoid Receptor Antagonists; Dronabinol; Hypothermia; Male; Motor Activity; Piperidines; Pyrazoles; Rats, Sprague-Dawley; Rimonabant; Telemetry | 2015 |
In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
Topics: Animals; Arachidonic Acids; Behavior, Animal; Benzodioxoles; Brain; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Glycerides; Hypothermia; Male; Mice; Monoacylglycerol Lipases; Nociception; Piperidines; Pyrazoles; Rimonabant | 2016 |
Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control.
Topics: Adiposity; Animals; Benzoxazines; Brain; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Feeding Behavior; Hypothermia; Male; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Obesity; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Sterol Regulatory Element Binding Protein 1; Tissue Distribution | 2010 |
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.
Topics: Animals; Calcium; Cannabinoid Receptor Modulators; Discrimination Learning; Diterpenes, Clerodane; Dronabinol; Guanosine 5'-O-(3-Thiotriphosphate); Hypothermia; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Pain Measurement; Piperidines; Pyrazoles; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptors, Opioid, kappa; Rimonabant; Salvia; Tetrahydroisoquinolines | 2010 |
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoids; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Hypothermia; Inflammation; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2010 |
Tolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia.
Topics: Animals; Behavior, Animal; Cannabinoids; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Hypothermia; Male; Mice; Mice, Inbred C57BL; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors | 2011 |
The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
Topics: Analysis of Variance; Animals; Arachidonic Acids; Body Temperature Regulation; Brain; Camphanes; Capsaicin; Disease Models, Animal; Diterpenes; Endocannabinoids; Female; Hypothermia; Injections, Intraperitoneal; Injections, Intravenous; Injections, Intraventricular; Lipopolysaccharides; Male; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Long-Evans; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Signal Transduction; Sulfonamides; Time Factors; TRPV Cation Channels | 2011 |
The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
Topics: Adiponectin; Adiposity; Animals; Anti-Obesity Agents; Biomarkers; Body Weight; Central Nervous System; Cholesterol; Diet, High-Fat; Energy Intake; Gastrointestinal Transit; Hypothermia; Insulin; Leptin; Mice; Mice, Knockout; Mice, Transgenic; MicroRNAs; Mutation; Obesity; Peripheral Nervous System; Phenotype; Piperidines; Promoter Regions, Genetic; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Triglycerides | 2011 |
Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.
Topics: Anilides; Animals; Benzoxazines; Body Temperature; Calcium Channel Blockers; Camphanes; Capsaicin; Cinnamates; Hypothermia; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; TRPV Cation Channels | 2005 |
Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats.
Topics: Amidohydrolases; Anilides; Animals; Arachidonic Acids; Body Temperature; Capsaicin; Cinnamates; Endocannabinoids; Hypothermia; Male; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; TRPV Cation Channels | 2006 |
NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
Topics: Aminoquinolines; Analgesics; Animals; Benzamides; Benzoxazines; Body Temperature; Cannabinoids; Humans; Hypothermia; Male; Morpholines; Naphthalenes; Narcotic Antagonists; Nociceptin Receptor; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2007 |
Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
Topics: Animals; Benzoxazines; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hypothermia; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors | 2007 |
Cannabinoid modulation of rat pup ultrasonic vocalizations.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Body Temperature; Cannabinoids; Cyclohexanols; Dopamine Antagonists; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; Hypothermia; Motor Activity; Naloxone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rimonabant; Vocalization, Animal | 1996 |
Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
Topics: Analysis of Variance; Animals; Body Temperature; Body Weight; Conditioning, Psychological; Cyclic AMP; Dronabinol; Drug Interactions; Hallucinogens; Hypothermia; In Vitro Techniques; Male; Mice; Motivation; Narcotics; Pain Measurement; Piperidines; Pyrazoles; Rimonabant; Substance Withdrawal Syndrome | 1998 |
Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoids; Crosses, Genetic; Dronabinol; Drug Tolerance; Hypothermia; Marijuana Abuse; Mice; Mice, Inbred Strains; Mice, Knockout; Motivation; Motor Activity; Piperidines; Psychotropic Drugs; Pyrazoles; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Rimonabant; Spatial Behavior; Substance Withdrawal Syndrome | 2002 |